Modern diagnostic approach to hereditary xanthinuria

Hereditary xanthinuria (HX) remains a rare condition with limited understanding of its diagnostic markers. Prior research has shown that HX results from xanthine dehydrogenase/oxidase (XDH/XO) deficiency. Established knowledge includes the role of XDH/XO in uric acid production. This gap motivated the need for better diagnostic tools. No prior work had resolved the limitations of invasive diagnostic methods. Traditional approaches relied on allopurinol tests and biopsies. These methods pose risks and are not always conclusive. This paper's contribution is a safer, non-invasive diagnostic algorithm.

The aim of this study is to propose a safer diagnostic approach for hereditary xanthinuria. The specific problem is the reliance on invasive and potentially harmful diagnostic methods. The motivation stems from the limitations of current techniques. This study introduces a three-step diagnostic algorithm. The first step involves biochemical analysis of uric acid and xanthine. The second step uses urinary metabolomics for typing. The third step confirms findings with molecular genetics. This approach aims to replace traditional methods like biopsies.

The study analyzed clinical and biochemical data from three new patients with HX. Urinary metabolomics was used to differentiate between HX types. Molecular genetics confirmed the presence of XDH/XO mutations. The first step involved measuring uric acid and xanthine levels. The second step used mass spectrometry for metabolite profiling. The third step employed DNA sequencing for confirmation. No invasive procedures like biopsies were used. The findings were compared to traditional diagnostic methods.

The three patients had undetectable uric acid levels and elevated xanthine. Urinary metabolomics successfully typed HX in each case. Molecular genetics confirmed XDH/XO mutations in all patients. No need for allopurinol tests or biopsies was observed. The three-step approach provided accurate diagnoses. The method was non-invasive and avoided unnecessary procedures. The results suggest a reliable alternative to traditional methods. This approach may improve diagnostic accuracy and safety.

The authors propose a three-step diagnostic algorithm for HX. This method replaces traditional allopurinol tests and biopsies. The first step involves biochemical analysis of uric acid and xanthine. The second step uses urinary metabolomics for typing. The third step confirms findings with molecular genetics. The authors suggest this approach is safer and more effective. The method avoids risks associated with invasive procedures. The findings support the use of non-invasive diagnostics for HX. This approach may be adopted in clinical practice.